JK
Julie Krop

Julie Krop insider trades: Aquestive Therapeutics (AQST) stock buys and sales

Aquestive Therapeutics Last trade Jun 23, 2026 26 Form 4 filings
$125K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
5
Open-market trades
since 2016
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Julie reports to the SEC

Open-market buys and sales

5 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 23, 2026AQST↓ Sell$125K
May 28, 2019AMAG↑ Buy$99K
Jul 13, 2017AMAG↓ Sell10b5-1$99K
May 1, 2017AMAG↓ Sell10b5-1$46K
Oct 20, 2016AMAG↓ Sell10b5-1$122K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AQST insiders

Open-market trades in the last 12 months

About Julie Krop's insider trades

Julie Krop is an insider at Aquestive Therapeutics (AQST). Since Oct 20, 2016, Julie has reported 1 open-market purchase worth $99K and 4 sales worth $393K on SEC Form 4. In the last 12 months: 1 sale ($125K).

3 sales (68% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (14 filings), shares withheld for taxes (8 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AQST insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.